Clinical Trials Logo

FANCA Gene Mutation clinical trials

View clinical trials related to FANCA Gene Mutation.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT03377556 Completed - BRCA1 Gene Mutation Clinical Trials

Lung-MAP: Talazoparib in Treating Patients With HRRD Positive Recurrent Stage IV Squamous Cell Lung Cancer

Start date: March 3, 2017
Phase: Phase 2
Study type: Interventional

This phase II trial studies how well talazoparib works in treating patients with homologous recombination repair deficiency (HRRD) positive stage IV squamous cell lung cancer that has come back after previous treatment. Talazoparib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.